SMAD3 and PINK1 Form a Feedback Loop That Amplifies Mitochondrial Cleanup

Mitophagy — the selective autophagy-lysosome-mediated degradation of dysfunctional mitochondria — is essential for maintaining cellular homeostasis, and its impairment is linked to neurodegeneration, aging, and metabolic disease. The PINK1-PRKN/parkin pathway is the best-characterized mitophagy mechanism: PINK1 accumulates on depolarized mitochondria, phosphorylates ubiquitin and parkin, and triggers a positive feedforward ubiquitination cascade that marks damaged mitochondria for degradation. However, a critical gap remained: how is PINK1 itself transcriptionally regulated when mitochondria are under stress, ensuring sufficient protein levels to sustain mitophagy?

This 'Autophagic Punctum' commentary from Tang, Lu, and Shen (Autophagy, 2025) highlights the authors' recent discovery of a novel regulatory axis involving SMAD3 (SMAD family member 3), a canonical transcriptional effector of TGF-β signaling. The central finding is that PINK1 and SMAD3 constitute a positive feedforward loop: PINK1 phosphorylates and activates SMAD3, and activated SMAD3 transcriptionally upregulates PINK1 expression, thus amplifying the mitophagy signal.

The mechanistic breakthrough lies in SMAD3 activation occurring through a non-canonical route. Upon mitochondrial depolarization — the classical trigger for PINK1 stabilization — PINK1 directly phosphorylates SMAD3 at serine residues 423 and 425. This is the same phosphorylation site used by canonical TGF-β receptor signaling, but here it happens independently of TGF-β ligand engagement. The phosphorylated SMAD3 then translocates to the nucleus and drives PINK1 transcription, creating a self-sustaining amplification loop that ensures robust mitophagy under stress conditions.

Functionally, the SMAD3-PINK1 axis appears to represent a pro-survival mechanism. By amplifying mitophagy, the loop enables more efficient removal of damaged mitochondria, reducing the risk of oxidative stress, inflammasome activation, and cell death. This positions SMAD3 not just as a mediator of fibrotic or growth-inhibitory TGF-β signals, but as a critical guardian of mitochondrial quality control.

The implications for longevity and age-related disease are significant. PINK1 loss-of-function mutations are a known cause of early-onset Parkinson's disease, and declining mitophagy is a hallmark of aging. The discovery that SMAD3 can transcriptionally sustain PINK1 under stress introduces a new therapeutic angle: modulating SMAD3 activity could potentially restore mitophagy in contexts where PINK1 expression is diminished. Furthermore, it raises important questions about how dysregulation of TGF-β-SMAD signaling — common in fibrosis, cancer, and aging — might inadvertently impair mitochondrial quality control. Future studies will need to map the full scope of SMAD3 target genes within the mitophagy program and determine how this loop is resolved once mitochondrial stress is cleared.